Less than a week after Angelina Jolie’s preventive double mastectomy disclosure, a London-based businessman had his prostate removed after being diagnosed with a mutated gene.
The DailyMail reports that one of the participants of a clinical trial by the Institute of Cancer Research in London decided to undergo the removal procedure for cancer prevention, which is pretty much the same reason as Jolie’s procedure. The businessman was told that he possessed BRCA2, which is a gene mutation similar to Jolie’s diagnosed condition.
BRCA2 or breast cancer type 2 susceptibility protein is known to increase the risk of breast cancer and ovarian cancer, and has recently been discovered as a probable cause of prostate cancer as well.
Doctors of the institute led by Roger Kirby were initially hesitant to do the procedure, since the MRI scans and a series of tests showed that the businessman’s prostate appeared to be in a healthy state. The procedure was only finalized when the medical team observed malignant changes in the prostate gland, which might develop into full-blown cancer.
This event serves as a giant step for men diagnosed with BRCA2 to undergo the preventive surgical procedure and raise awareness on the negative effects of the mutant gene. Kirby also hopes that it also emphasizes the importance of prostate cancer prevention in the country.
The businessman, whose identity has been kept under wraps, is now declared by Kirby to be 100 percent clear of BRCA2. He is currently residing in London with his wife and kids.Tags: BRCA2 gene, cancer prostate, prostate cancer prevention